Relevant targets for therapy with monoclonal antibodies in allograft transplantation.
Soulillou
J P
JP
Institut de Transplantation et de Recherche en Transplantation, Institut National de la Santé et de la Recherche Medicale (INSERM U.211).
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D018845:CD11 Antigens / Q000276:immunology*; D005260:Female; D006084:Graft Rejection / Q000628:therapy*; D006085:Graft Survival / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation; D008875:Middle Aged; D016032:Randomized Controlled Trials as Topic; D013601:T-Lymphocytes / Q000276:immunology*; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D018845:CD11 Antigens; D007166:Immunosuppressive Agents